GC
LFCR icon

Guggenheim Capital’s Lifecore Biomedical LFCR Stock Holding History

Guggenheim Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-158,435
Closed -$2.19M – 2894
2016
Q4 		$2.19M Sell
158,435
-61,645
-28% -$854K 0.01% 1607
2016
Q3 		$2.95M Sell
220,080
-152,074
-41% -$1.84M 0.01% 1343
2016
Q2 		$4M Sell
372,154
-176,236
-32% -$1.94M 0.01% 1113
2016
Q1 		$5.76M Sell
548,390
-41,263
-7% -$453K 0.02% 915
2015
Q4 		$6.98M Sell
589,653
-215,442
-27% -$2.65M 0.02% 886
2015
Q3 		$9.39M Sell
805,095
-436,962
-35% -$5.79M 0.03% 779
2015
Q2 		$17.9M Sell
1,242,057
-613,971
-33% -$8.86M 0.04% 637
2015
Q1 		$25.9M Sell
1,856,028
-145,880
-7% -$2.02M 0.06% 576
2014
Q4 		$27.6M Sell
2,001,908
-539,180
-21% -$6.97M 0.07% 511
2014
Q3 		$31.1M Sell
2,541,088
-26,584
-1% -$332K 0.07% 465
2014
Q2 		$32.1M Buy
2,567,672
+22,118
+0.9% +$260K 0.08% 437
2014
Q1 		$28.4M Sell
2,545,554
-95,639
-4% -$1.05M 0.08% 415
2013
Q4 		$32M Buy
2,641,193
+311,824
+13% +$3.72M 0.1% 300
2013
Q3 		$28.4M Buy
2,329,369
+79,798
+4% +$1.11M 0.1% 253
2013
Q2 		$29.7M Buy
+2,249,571
New +$31.1M 0.13% 167

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Guggenheim Capital's LFCR Position: Q1 2017 in Review

Guggenheim Capital sold out of Lifecore Biomedical (LFCR) in Q1 2017, closing a stake of 158,435 shares — an estimated $2.19M sold.

Guggenheim Capital first reported a position in LFCR in Q2 2013 and held it in 15 quarters. The position peaked at $32.1M in Q2 2014. 86 funds tracked by Wall St. Rank hold LFCR as of Q1 2017.

  • Guggenheim Capital reported no remaining Lifecore Biomedical position as of Q1 2017 after selling out during the quarter.
  • Guggenheim Capital sold 158,435 Lifecore Biomedical shares in Q1 2017, an estimated $2.19M.
  • Guggenheim Capital first reported a position in Lifecore Biomedical in Q2 2013 and held it in 15 quarters.
  • Guggenheim Capital's Lifecore Biomedical position peaked at $32.1M in Q2 2014.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2017.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.